Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by mercedesmanon Jul 26, 2022 10:31am
233 Views
Post# 34850858

Kellum Kudos

Kellum KudosKudos to Kellum for participating with the Sepsis Alliance/Sepsis Day, for now the second year in a row.

For decades, it seems, Spectral remained silent when it came to the Sepsis Alliance.  Nary a hint that they could provide some hope to Sepsis sufferors and their families.

That appears to be changing.

https://stockhouse.com/news/press-releases/2022/07/26/spectral-medical-s-chief-medical-officer-dr-john-kellum-to-be-the-featured

MM
<< Previous
Bullboard Posts
Next >>